Healthcare • Biotechnology
EODHD (TTM) · as of Oct 13, 2026
End-of-day close from stored market data, not a live quote.
Sign in to see your position size
We’ll show you if TBPH is in your portfolio and how much it contributes.
Sign inLoading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
25 top institutions tracked
Last 13F trend: distributing (light)
Unlock crowding heatmapUnlock filer discoverySentiment: unknown
No recent insider trades detected.
Red flags: 1
181 filers reported a long position in TBPH for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| Madison Avenue Partners, LP | $156.6M | 9.2M | -3.1% |
| Weiss Asset Management LP | $126.8M | 7.5M | Unchanged |
| BlackRock, Inc. | $77.6M | 4.6M | +6.2% |
| Newtyn Management, LLC | $58.4M | 3.4M | -29.1% |
| Irenic Capital Management LP | $46.9M | 2.8M | Unchanged |
| VANGUARD CAPITAL MANAGEMENT LLC | $30.1M | 1.8M | -0.7% |
| STATE STREET CORP | $22.6M | 1.3M | +2.4% |
| TWO SIGMA INVESTMENTS, LP | $20.8M | 1.2M | -2.6% |
| D. E. Shaw & Co., Inc. | $20.2M | 1.2M | +24.2% |
| ACADIAN ASSET MANAGEMENT LLC | $20M | 1.2M | -8% |
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.